.Exelixis is quiting on its own tissue factor (TF)- targeting antibody-drug conjugate after ending t...
.Three weeks after Roche's Genentech unit left an SHP2 prevention pact, Relay Rehab has validated th...
.Stoke Therapeutics' Dravet disorder medicine has actually been freed from a partial grip, getting r...
.Tough Biotech Associate Publisher Gabrielle Masson presented the 2024 course of Fierce 15 champions...
.Novo Nordisk has axed its once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) advancement o...
.Merck & Co. has actually promptly made back a number of the costs of its own Harp on Therapies b...
.After BioMarin administered a spring tidy of its pipe in April, the provider has actually chosen th...
.Big Pharmas remain stuck to the idea of molecular adhesive degraders. The most recent provider to v...
.A new worldwide lifestyle science credit report firm, referred to as Symbiotic Resources, has actua...
.Bristol Myers Squibb is axing another major wager from the Caforio age, canceling an offer for Agen...